Clinical Laserthermia Systems Management
Management criteria checks 4/4
Clinical Laserthermia Systems' CEO is Dan Mogren, appointed in Dec 2020, has a tenure of 3.42 years. total yearly compensation is SEK1.37M, comprised of 74.3% salary and 25.7% bonuses, including company stock and options. directly owns 0.008% of the company’s shares, worth SEK9.92K. The average tenure of the management team and the board of directors is 2.3 years and 3.3 years respectively.
Key information
Dan Mogren
Chief executive officer
kr1.4m
Total compensation
CEO salary percentage | 74.3% |
CEO tenure | 3.4yrs |
CEO ownership | 0.008% |
Management average tenure | 2.3yrs |
Board average tenure | 3.3yrs |
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -kr80m |
Sep 30 2023 | n/a | n/a | -kr63m |
Jun 30 2023 | n/a | n/a | -kr77m |
Mar 31 2023 | n/a | n/a | -kr78m |
Dec 31 2022 | kr1m | kr1m | -kr71m |
Sep 30 2022 | n/a | n/a | -kr81m |
Jun 30 2022 | n/a | n/a | -kr63m |
Mar 31 2022 | n/a | n/a | -kr68m |
Dec 31 2021 | kr2m | kr1m | -kr64m |
Compensation vs Market: Dan's total compensation ($USD126.90K) is below average for companies of similar size in the Swedish market ($USD252.27K).
Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.
CEO
Dan Mogren (59 yo)
3.4yrs
Tenure
kr1,373,158
Compensation
Mr. Dan Johansson Mogren was Acting Chief Executive Officer at Clinical Laserthermia Systems AB (publ) since December 01, 2020 until May 2022 and is Chief Executive Officer May 2022 and served as its Chief...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 3.4yrs | kr1.37m | 0.0080% SEK 9.9k | |
Co-Founder & Director | no data | kr1.65m | no data | |
Interim Chief Financial Officer | less than a year | no data | no data | |
Executive Vice President of Operations | less than a year | no data | no data | |
Chief Technical Officer | 2.3yrs | no data | no data | |
Vice President of Marketing | 3.3yrs | no data | 0.0013% SEK 1.6k | |
Chief Product Officer | no data | no data | no data |
2.3yrs
Average Tenure
56yo
Average Age
Experienced Management: CLS B's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Director | 18.3yrs | kr1.65m | no data | |
Director | 2.3yrs | kr75.00k | 0.0099% SEK 12.2k | |
Independent Chairman of the Board | 11.3yrs | kr250.00k | 0.085% SEK 104.5k | |
Independent Director | 4.3yrs | kr142.50k | no data | |
Member of Clinical Advisory Board | 2.9yrs | kr80.00k | no data | |
Member of Clinical Advisory Board | 2.9yrs | kr80.00k | 0.14% SEK 170.5k | |
Independent Director | 3.3yrs | kr62.50k | 0.0013% SEK 1.6k | |
Independent Director & Member of Clinical Advisory Board | 4.3yrs | kr142.50k | 0.00037% SEK 456.0 | |
Independent Director | 3.3yrs | no data | no data |
3.3yrs
Average Tenure
68yo
Average Age
Experienced Board: CLS B's board of directors are considered experienced (3.3 years average tenure).